// App-Quantinova.ai

1447 : Major Bleeding Events Among Cancer and Non-Cancer Patients Taking Rivaroxaban for Venous Thromboembolism Treatment in a Department of Defense Health System Cohort

Researchers

Presenter

  • Alok A. Khorana

Principal Investigators

  • Frank Peacock

  • Sally G Tamayo

  • Zhong Yuan

  • Nicholas Sicignano

  • Kathleen Hopf

  • Manesh Patel

Medical Centers

  • Pediatric Hospital Medicine, Baylor College of Medicine, Houston, TX

  • Duke University Health System and Duke Clinical Research Institute, Durham, NC

  • Naval Medical Center Portsmouth, Portsmouth, VA

  • Taussig Cancer Institute Cleveland Clinic, Cleveland, OH

Locations

  • United States

Companies

  • JB Medical Ltd.

  • Health ResearchTx LL

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • B-Cell Non-Hodgkin Lymphoma

  • Lymphomas

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved